Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene Journal Article
| Authors: | Meehan, M.; Parthasarathi, L.; Moran, N.; Jefferies, C. A.; Foley, N.; Lazzari, E.; Murphy, D.; Ryan, J.; Ortiz, B.; Fabius, A. W.; Chan, T. A.; Stallings, R. L. |
| Article Title: | Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene |
| Abstract: | Background: Protein tyrosine phosphatase receptor delta (PTPRD) is a member of a large family of protein tyrosine phosphatases which negatively regulate tyrosine phosphorylation. Neuroblastoma is a major childhood cancer arising from precursor cells of the sympathetic nervous system which is known to acquire deletions and alterations in the expression patterns of PTPRD, indicating a potential tumor suppressor function for this gene. The molecular mechanism, however, by which PTPRD renders a tumor suppressor effect in neuroblastoma is unknown.Results: As a molecular mechanism, we demonstrate that PTPRD interacts with aurora kinase A (AURKA), an oncogenic protein that is over-expressed in multiple forms of cancer, including neuroblastoma. Ectopic up-regulation of PTPRD in neuroblastoma dephosphorylates tyrosine residues in AURKA resulting in a destabilization of this protein culminating in interfering with one of AURKA's primary functions in neuroblastoma, the stabilization of MYCN protein, the gene of which is amplified in approximately 25 to 30% of high risk neuroblastoma.Conclusions: PTPRD has a tumor suppressor function in neuroblastoma through AURKA dephosphorylation and destabilization and a downstream destabilization of MYCN protein, representing a novel mechanism for the function of PTPRD in neuroblastoma. © 2012 Meehan et al; BioMed Central Ltd. |
| Keywords: | protein expression; unclassified drug; oncoprotein; human cell; genetics; mortality; cancer risk; metabolism; apoptosis; gene amplification; gene expression; gene expression profiling; protein; protein binding; protein stability; protein interaction; cell line, tumor; protein serine threonine kinase; tyrosine; phosphorylation; neuroblastoma; protein-serine-threonine kinases; oncogene proteins; tumor suppressor proteins; tumor cell line; upregulation; tumor suppressor; protein tyrosine phosphatase; protein dephosphorylation; receptor-like protein tyrosine phosphatases, class 2; tumor suppressor protein; aurora a kinase; enzyme stability; mycn; aurka; ptprd; mycn protein; protein tyrosine phosphatase receptor delta; aurora kinase; receptor like protein tyrosine phosphatase |
| Journal Title: | Molecular Cancer |
| Volume: | 11 |
| ISSN: | 1476-4598 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2012-02-05 |
| Start Page: | 6 |
| Language: | English |
| DOI: | 10.1186/1476-4598-11-6 |
| PROVIDER: | scopus |
| PUBMED: | 22305495 |
| PMCID: | PMC3395855 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 April 2012" - "CODEN: MCOAC" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work